Sponsor or institution

Clinical trials and research at Peking University People's Hospital

• 126Clinical trials
• 4New in 30 days
• 1Country

Newest trials

All recruiting trials (126)

• Interferon-α Maintenance for Favorable-Risk AML

  This study tests pegylated interferon alfa-2b as maintenance therapy to see if it helps keep favorable-risk AML in remission after initial treatment.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT07925554

• HLH after stem cell transplant: can routine blood tests flag risk in the next week?

  This study tests whether changes in common blood tests and clinical data can predict HLH within seven days after a first allogeneic stem cell transplant.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07905066

• MRD-guided postoperative monitoring and adaptive treatment for resectable NSCLC

  This study tests a personalized follow-up and treatment plan using ctDNA MRD testing and pathology to guide adjuvant therapy after surgery for stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07894458

• ctDNA testing in newly diagnosed DLBCL or HGBL to predict treatment outcomes

  This study checks if measuring circulating tumor DNA in blood after first-line therapy can predict whether the disease will stay away or come back in people with DLBCL or HGBL.

  Recruiting at 2 sites Peking University People's Hospital · Beijing, Beijing Municipality and 1 other locations · NCT07878351

• LECS with sentinel node navigation for early gastric cancer

  This study tests whether combining LECS with sentinel node navigation can treat early gastric cancer while preserving stomach function in eligible patients.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07857668

• Pilonidal sinus care with VAAPS and loose seton drainage after VAAPS

  This study tests whether adding a loose glove-edge seton drainage to VAAPS can allow patients to manage wound care at home without daily flushing.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07855107

• Telitacicept for primary Sjögren’s with interstitial lung disease

  This study tests whether Telitacicept helps people with primary Sjögren’s syndrome and interstitial lung disease compared with standard immunosuppressants.

  Recruiting Peking University People's Hospital · Beijing · NCT07843381

• Comprehensive tubal function assessment and personalized treatment for tubal factor infertility

  This study tests a new multi-dimensional way to diagnose tubal problems and to improve natural pregnancy after tubal surgery using a special anti-adhesion material and refined techniques.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07808229

• Telitacicept for difficult-to-treat rheumatoid arthritis

  This study tests whether adding telitacicept to standard therapy helps adults with hard-to-treat rheumatoid arthritis see better control of their symptoms.

  Recruiting Phase 2 Peking University People's Hospital · Hefei, Anhui and 46 other locations · NCT07796516

• Testing an ICU time-series model to predict mortality at a major hospital

  We will see if a pre-trained time-series model can accurately forecast outcomes for ICU patients using real-world data.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07795450

• Dynamic ProGRP Changes During Ewing Sarcoma Treatment

  This study tests whether changes in serum ProGRP levels over time reflect how well newly diagnosed Ewing sarcoma responds to treatment.

  Recruiting Peking University People's Hospital · Beijing · NCT07725783

• Age-stratified conditioning regimens to improve outcomes in haploidentical stem cell transplant for myelodysplastic syndrome

  This study tests two conditioning regimens in adults with MDS undergoing haploidentical stem cell transplant to see how age affects outcomes over one year.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT07677306

• Coated Aldehyde Oxystarch to lower PBUTs in adults on dialysis

  This study tests whether a coated oral adsorbent called Coated Aldehyde Oxystarch (Xiqing) can lower protein-bound uremic toxins in adults on maintenance dialysis and checks its safety.

  Recruiting Peking University People's Hospital · Beijing · NCT07653711

• Aflibercept 8 mg in real-world neovascular AMD

  This study tests how well aflibercept 8 mg works in real-world patients with neovascular AMD, including those new to treatment and those who have been treated before.

  Recruiting at 6 sites Peking University People's Hospital · Beijing, Beijing Municipality and 26 other locations · NCT07640997

• A new treatment model for elderly lung cancer patients

  This trial tests a comprehensive, integrated care approach for older adults with lung cancer to improve perioperative management and outcomes.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07632664

• Peripheral Blood Stem Cells Alone vs Bone Marrow Plus Peripheral Blood for Haploidentical Transplants in Severe Aplastic Anemia

  This study tests whether using peripheral blood stem cells alone work as well as the usual bone marrow plus peripheral blood grafts for patients with severe aplastic anemia who lack a fully matched donor.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07629947

• IASO207 injections for active refractory SLE (first-in-human)

  This early-stage study tests a new in vivo CAR-T therapy called IASO207 to see if it is safe and potentially helpful for adults with active, treatment-resistant SLE.

  Recruiting Early Phase 1 Peking University People's Hospital · Beijing · NCT07617740

• Allogeneic CAR-T CT0890B for relapsed/refractory AML

  This study tests whether a universal CAR-T cell therapy called CT0890B is safe and potentially effective for adults with relapsed or refractory acute myeloid leukemia who express NKG2D ligands.

  Recruiting Phase 1 Peking University People's Hospital · Beijing · NCT07617285

• Pyrotinib-based regimens for advanced HER2-positive breast cancer: real-world sequential therapy after progression

  This real-world study tests whether giving disitamab vedotin after pyrotinib-based treatment helps people with advanced HER2-positive breast cancer.

  Recruiting Phase 4 Peking University People's Hospital · Beijing, Beijing Municipality · NCT07600164

• Thiotepa-based conditioning regimen before allogeneic stem cell transplant for CMML

  This study tests a thiotepa-containing conditioning plan before an allogeneic stem cell transplant in adults with intermediate-2 or high-risk CMML to see if it improves outcomes.

  Recruiting Peking University People's Hospital · Beijing · NCT07588594

• Romiplostim N01 plus ATRA for persistent chemotherapy-induced low platelets after remission from gynecologic, breast, or lung cancer

  This trial tests whether adding ATRA to Romiplostim N01 helps people keep a safe platelet count after finishing chemotherapy for certain cancers.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT07586826

• Romiplostim N01 plus ATRA for persistent low platelets after cancer remission

  This study tests whether adding all-trans retinoic acid to Romiplostim N01 helps people who still have low platelets after GI/digestive system cancer remission reach safer platelet levels.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT07586813

• BFCA conditioning for Haplo-HSCT in older adults with severe aplastic anemia

  This study tests the BFCA conditioning regimen in adults aged 40–60 with severe aplastic anemia undergoing haploidentical stem cell transplant to see if it’s safe and effective.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07586735

• IASO207 Injection for relapsed or refractory B-cell cancers

  This early, single-center study tests IASO207 injections to see if they are safe and potentially beneficial for adults with relapsed or refractory B-cell malignancies who have not responded to standard therapies.

  Recruiting Early Phase 1 Peking University People's Hospital · Beijing · NCT07574346

• Tracking invasive fungal infections after allogeneic hematopoietic stem cell transplant

  We will follow people who had an allogeneic stem cell transplant to see how often serious fungal infections occur and which clinical factors predict them.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07569055

• Leukemia stem cell test to predict relapse and survival in AML with MLL rearrangement.

  This project will test if measuring leukemia stem cells in people aged 6–60 with AML and MLL rearrangement can predict relapse and survival.

  Recruiting Peking University People's Hospital · Beijing · NCT07537738

• Baricitinib for persistent low platelets after stem cell transplant

  We’re testing baricitinib to see if it can help people with long-term low platelets after an allogeneic stem cell transplant who didn’t respond to other treatments.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT07535645

• Vitreous zonule and its role in primary angle-closure glaucoma.

  This project will try 3D ultrasound imaging to see if the vitreous zonule contributes to angle-closure glaucoma in adults with or at risk for primary angle-closure disease and in healthy people.

  Recruiting Peking University People's Hospital · Beijing · NCT07523139

• Light exposure during general anesthesia

  This test checks whether covering patients' eyes during general anesthesia changes how much anesthetic adults (18–65) need.

  Recruiting Peking University People's Hospital · Beijing · NCT07517484

• Kahook Dual Blade goniotomy added to cataract surgery for chronic angle-closure glaucoma

  This trial will test whether adding Kahook Dual Blade goniotomy to cataract surgery and goniosynechialysis better lowers eye pressure in people aged 40 and older with chronic primary angle-closure glaucoma and cataract.

  Recruiting Peking University People's Hospital · Beijing · NCT07517302

• Digital PCR monitoring of residual AML after allogeneic stem-cell transplant in patients with clonal hematopoiesis

  This will test whether personalized digital PCR can find tiny amounts of leukemia after allogeneic stem-cell transplant in AML patients who have clonal hematopoiesis or myelodysplasia-related mutations.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07500441

• FAP-targeted PET and near-infrared fluorescence imaging for resectable non-small cell lung cancer

  We are testing whether FAP-targeted PET and near-infrared fluorescence can help find residual tumor and guide surgery in people with stage II–IIIB resectable non-small cell lung cancer after neoadjuvant therapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07498933

• PET scan targeting CDH3 for lung tumors

  This will test whether a new PET imaging agent called 68Ga-TOI-1 that targets CDH3 can better detect and stage lung tumors and help tell malignant from benign pulmonary nodules in adults with suspected or confirmed non-small cell lung cancer.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07487883

• Ablation versus breast-conserving surgery for early hormone receptor–positive breast cancer

  This trial will test whether a minimally invasive hybrid cryo-thermal ablation works as well as breast-conserving surgery for women aged 50 and older with a single, small ER/PR-positive, HER2-negative early breast cancer.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07484087

• Apatinib plus liposomal irinotecan for refractory or metastatic osteosarcoma

  This trial tests whether combining the oral drug apatinib with intravenous liposomal irinotecan helps patients whose osteosarcoma has progressed after standard chemotherapy.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing · NCT07479732

• Advanced imaging and AI for detecting and staging osteoporosis and osteoarthritis

  This project will see if an AI system can use routine X‑rays, CT, and MRI to accurately diagnose and stage osteoporosis and osteoarthritis in adults.

  Recruiting Peking University People's Hospital · Beijing · NCT07474571

• Subcutaneous methotrexate for Chinese adults with rheumatoid arthritis

  This project will test how well and how safely subcutaneous methotrexate works for Chinese adults with rheumatoid arthritis, including people with lung or coronary comorbidities.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07463937

• CD19 CAR-T versus donor lymphocyte infusion for clearing MRD after allogeneic stem cell transplant in Ph-negative B-ALL

  This trial tests whether a single infusion of autologous CD19 CAR-T cells or chemotherapy plus donor lymphocyte infusion better clears minimal residual disease in patients aged 3–79 with Ph-negative B‑cell ALL after allogeneic stem cell transplant.

  Recruiting Phase 3 Peking University People's Hospital · Beijing, China · NCT07441291

• Does daily activity and exercise-induced irisin influence brain function and postoperative delirium in older adults?

  This study tests whether exercise-related irisin levels are linked to postoperative delirium in adults 65 and older undergoing non-cardiovascular surgery with spinal anesthesia.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07424170

• Imaging epithelial tumors with an EpCAM-targeted PET tracer

  This test uses a new EpCAM-targeted PET tracer, [68Ga]Ga-PN-EpC1, to see if it safely detects EpCAM-positive tumors in adults scheduled for biopsy or surgical treatment.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07400263

• Intrauterine type III collagen injection plus progestin for fertility-preserving endometrial cancer or atypical hyperplasia

  This test sees if adding an intrauterine injection of recombinant humanized type III collagen to high‑dose progestin helps women with early endometrial cancer or atypical hyperplasia preserve fertility and achieve tumor remission.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT07377734

• Early screening and diagnosis of lung nodules using non-invasive biomarkers and imaging.

  This project will test whether combining breath and blood metabolite profiles with CT image features and blood DNA can better detect early lung cancer in adults with small pulmonary nodules.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07370077

• CDK4/6 inhibitors with endocrine therapy before surgery for HR+/HER2- high-risk early breast cancer

  This study tests whether adding a CDK4/6 inhibitor to endocrine therapy before surgery can help guide safer de-escalation of chemotherapy using ctDNA as a marker.

  Recruiting Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT07366112

• Ivonescimab in Neoadjuvant NSCLC: Testing a PD-1/VEGF Bi-specific

  This study tests Ivonescimab, a PD-1/VEGF bispecific antibody, in people with non-small cell lung cancer to see if it works better or has different safety than standard PD-1 inhibitors before surgery.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07359040

• Cardiovascular outcomes after hematopoietic stem cell transplantation

  We will collect clinical, laboratory, and treatment data from people who had hematopoietic stem cell transplants to see if certain factors are linked to heart and blood vessel problems after transplant.

  Recruiting at 16 sites Peking University People's Hospital · Beijing, Beijing Municipality and 15 other locations · NCT07349498

• Dual CD19 and CD20 CAR-T therapy for relapsed or refractory aggressive B-cell lymphoma

  This trial will try a CAR-T treatment that targets both CD19 and CD20 for adults whose aggressive B-cell lymphoma has relapsed or not responded to prior therapies.

  Recruiting Early Phase 1 Peking University People's Hospital · Beijing, Beijing Municipality · NCT07344818

• Sonrotoclax plus dexamethasone with or without daratumumab for t(11;14) AL amyloidosis

  This study tests whether adding sonrotoclax (a BCL-2 inhibitor) to dexamethasone, with or without daratumumab, helps people with t(11;14) positive AL amyloidosis.

  Recruiting at 2 sites Phase 2 Peking University People's Hospital · Beijing and 2 other locations · NCT07335887

• Using hepatitis B immunoglobulin to boost lasting cure after peginterferon in chronic hepatitis B

  This trial will test whether giving hepatitis B immunoglobulin to adults who cleared HBsAg after peginterferon helps them develop protective anti‑HBs antibodies and lowers the chance of relapse.

  Recruiting Early Phase 1 Peking University People's Hospital · Beijing, Beijing Municipality · NCT07328711

• Diet approaches to help overweight women with endometrial cancer preserve fertility and lose weight

  This study will see if intermittent fasting or a low-energy balanced diet help overweight or obese women with endometrial cancer lose weight and improve metabolic and tumor-related outcomes while they undergo fertility-preserving treatment.

  Recruiting Peking University People's Hospital · Beijing · NCT07318727

• First-line immunotherapy in Chinese adults with newly diagnosed multiple myeloma

  This study will test how first-line immunotherapy treatments—including anti-CD38 antibodies, proteasome inhibitors, and IMiDs—work in adults newly diagnosed with multiple myeloma in China over one year.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07296627

• Multi-omics blood and CT monitoring for early detection of lung cancer recurrence after neoadjuvant therapy and surgery

  This project tests whether combining blood-based multi-omics (metabolomics and cfDNA), CT radiomics, and AI can noninvasively detect early recurrence after surgery in NSCLC patients treated with neoadjuvant immunotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07291921

• CD7 CAR‑T therapy for MRD‑positive T‑ALL/LBL after allogeneic transplant

  This trial will test a single infusion of CD7‑targeted CAR‑T cells to see if they can clear measurable residual disease in people with CD7‑positive T‑ALL or T‑LBL after an allogeneic stem cell transplant.

  Recruiting Phase 1 Peking University People's Hospital · Beijing, China · NCT07280494

• Combined cryoablation and thermal ablation for non-surgical breast cancer treatment

  This study will test whether a combined freezing and heating ablation approach can safely treat adults with biopsy-confirmed breast cancer who cannot or will not have surgery.

  Recruiting Peking University People's Hospital · Beijing · NCT07238894

• Transplanting your own skin cells to restore pigment in vitiligo

  This procedure will try transplanting a suspension made from your own skin cells to restore pigment in people aged 8–65 with stable vitiligo that hasn't improved with medicine or light therapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07187882

• CIGB-814 safety and how the body handles it in healthy Chinese adults

  We will test whether CIGB-814 is safe, well-tolerated, and how the body processes it in healthy Chinese adults aged 18–45.

  Recruiting Phase 1 Peking University People's Hospital · Beijing, Beijing Municipality · NCT07182656

• Automated bone age estimation from routine abdominal CT using AI

  This project will try to use routine noncontrast abdominal CT scans and deep learning to estimate bone age in adults who had these scans for other medical reasons.

  Recruiting Peking University People's Hospital · Beijing · NCT07162168

• CD7-targeted CAR-T therapy for relapsed or refractory peripheral T-cell lymphoma

  This study will try CD7-targeted CAR-T cells in adults with relapsed or refractory CD7-positive peripheral T-cell lymphoma.

  Recruiting Phase 1 Peking University People's Hospital · Beijing · NCT07143929

• Four-hour pHA130 hemoadsorption with hemodialysis

  We will test whether using pHA130 hemoadsorption for 4 hours instead of 2 during regular dialysis removes more protein-bound toxins like indoxyl sulfate in people on maintenance hemodialysis.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07111260

• Predicting pregnancy risks for women with aplastic anemia

  This project will try to create a model to predict which pregnant women with aplastic anemia are most likely to have maternal or newborn complications.

  Recruiting Peking University People's Hospital · Beijing · NCT07101770

• Teriflunomide plus high-dose dexamethasone versus high-dose dexamethasone alone for adults with newly diagnosed ITP

  This trial tests whether adding teriflunomide to high-dose dexamethasone helps adults with newly diagnosed immune thrombocytopenia raise platelet counts and control bleeding better than dexamethasone alone.

  Recruiting at 3 sites Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality and 2 other locations · NCT07065968

• Fucoidan for active rheumatoid arthritis

  This trial will test whether fucoidan, a seaweed-derived SR-A inhibitor, can reduce disease activity in adults (18–65) with active rheumatoid arthritis who have moderate-to-high disease activity despite current treatment.

  Recruiting Peking University People's Hospital · Beijing · NCT07045896

• Long-term outcomes for adults with lupus at Peking University People's Hospital

  This project will follow adults with lupus at Peking University People's Hospital for up to 10 years to see how disease activity, organ involvement, achievement of Lupus Low Disease Activity State (LLDAS), and survival change over time.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07005479

• Lower-dose ATG plus mini post‑transplant cyclophosphamide to prevent GVHD after haploidentical stem cell transplant

  This approach tries a lower dose of ATG combined with a short course of post‑transplant cyclophosphamide to prevent graft‑versus‑host disease in people aged 12–65 receiving a haploidentical stem cell transplant for acute leukemia or myelodysplastic syndrome.

  Recruiting Phase 2 Peking University People's Hospital · Beijing · NCT06984536

• ctDNA-guided reduction of chemotherapy using dalpiciclib plus endocrine therapy in high-risk HR+/HER2- early breast cancer

  This trial tests whether giving the CDK4/6 drug dalpiciclib with endocrine therapy and using ctDNA results can let some women with early high-risk HR+/HER2- breast cancer skip or reduce chemotherapy.

  Recruiting Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06970912

• Geriatric Assessment to support older patients undergoing allo-HSCT

  This study tests a multidimensional geriatric assessment to see how age, health, and disease factors relate to outcomes for older adults undergoing allogeneic stem cell transplantation.

  Recruiting Peking University People's Hospital · Beijing · NCT06946654

• Conditioning regimens for elderly AML patients receiving haplo-HSCT

  This trial tests whether a fludarabine-based conditioning plan (Bu/Flu/Cy/ATG) reduces transplant-related mortality compared with a cyclophosphamide-based plan (Bu/Cy/ATG) in elderly AML patients getting haploidentical stem cell transplants.

  Recruiting Peking University People's Hospital · Beijing · NCT06946602

• New method for monitoring lung cancer after surgery

  This study is testing a new way to monitor lung cancer after surgery using blood tests to see if it helps patients stay cancer-free longer compared to standard methods.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06930807

• Nanobody-based CAR-T therapy for relapsed B-cell leukemia

  This study is testing a new type of CAR-T therapy to see if it can help people with relapsed B-cell leukemia who haven't had success with other treatments.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06880913

• Consolidation therapy for newly diagnosed multiple myeloma after transplant

  This study is testing if a combination treatment after a stem cell transplant can help people with newly diagnosed multiple myeloma have better outcomes and stay in remission longer.

  Recruiting at 3 sites Phase 2/3 Peking University People's Hospital · Beijing, Beijing Municipality and 2 other locations · NCT06879379

• Nanobody-based CAR-T therapy for relapsed T-cell leukemia and lymphoma

  This study is testing a new type of CAR-T therapy using nanobodies to see if it can help people with relapsed T-cell leukemia or lymphoma feel better and live longer.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06874946

• Evaluating Upadacitinib for treating relapsing polychondritis

  This study is testing if a new medication called Upadacitinib can help adults with relapsing polychondritis feel better compared to standard treatments like steroids and immunosuppressants.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06873100

• Thiotepa, busulfan, and fludarabine treatment for elderly patients with high-risk acute myeloid leukemia

  This study is testing a new treatment plan using thiotepa, busulfan, and fludarabine to see if it helps older patients with high-risk acute myeloid leukemia stay cancer-free after a stem cell transplant.

  Recruiting Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06869265

• Using Interferon-alpha to maintain remission in favorable-risk Acute Myeloid Leukemia

  This study is testing if a treatment called Interferon-alpha can help keep patients with favorable-risk Acute Myeloid Leukemia in remission after they’ve completed chemotherapy.

  Recruiting Phase 3 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06802718

• BCMA-CD19 CAR-T therapy for autoimmune diseases

  This study is testing a new CAR-T cell therapy to see if it can help adults with tough autoimmune diseases feel better and improve their health.

  Recruiting Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06794008

• Using a targeted probe to improve surgery for osteosarcoma

  This study is testing a special probe to see if it can help doctors remove osteosarcoma tumors more completely during surgery.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06778603

• Comparing two biopsy methods for diagnosing stomach tumors

  This study is testing which biopsy method works better for diagnosing stomach tumors in patients with larger growths to help doctors make better treatment decisions.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06748690

• Endoscopic and robotic nipple-sparing mastectomy with immediate breast reconstruction

  This study is testing a new type of breast surgery that uses advanced techniques to remove cancer while keeping the nipple and immediately placing an implant to see if it helps patients feel better about their appearance and recover well.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06748677

• Observational study of blood clotting and bleeding disorders in Chinese patients

  This study looks at blood clotting and bleeding problems in Chinese patients to see how common they are and what factors might affect them.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality and 4 other locations · NCT06727669

• Using Type III Collagen to Improve Outcomes After Breast Tumor Surgery

  This study is testing if a special type of collagen can help breast cancer patients recover better and have fewer complications after their surgery.

  Recruiting Phase 1 Peking University People's Hospital · Beijing, China · NCT06725082

• Combining chemotherapy and targeted therapy for early HER2 positive breast cancer

  This study is testing if combining chemotherapy with targeted therapy can help people with early HER2 positive breast cancer feel better while using less chemotherapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06722612

• Neoadjuvant therapy for low-risk HER2-positive breast cancer patients

  This study is testing a new treatment plan for people with low-risk HER2-positive breast cancer to see if combining certain chemotherapy drugs with targeted therapy can work just as well with less intense treatment.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06722599

• Using Trilaciclib with Chemotherapy for Osteosarcoma Treatment

  This study is testing if adding Trilaciclib to chemotherapy can help protect the bone marrow of patients with stage II/III classic osteosarcoma during treatment.

  Recruiting Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06714383

• Targeted therapy for early HER2-positive breast cancer with no lymph node involvement

  This study is testing whether a new treatment approach that combines targeted therapy with less chemotherapy can help women with early HER2-positive breast cancer and no lymph node involvement feel better while reducing side effects.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06711068

• Combining taxane chemotherapy with targeted therapy for low-risk HER2 positive breast cancer

  This study is testing if combining a type of chemotherapy with a targeted therapy can safely treat patients with low-risk HER2 positive breast cancer and reduce the need for stronger treatments.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06711055

• Comparing capecitabine treatments for patients with residual triple negative breast cancer after initial therapy

  This study is testing two different ways of giving capecitabine to people with triple negative breast cancer who didn't fully respond to their initial treatment to see which one works better and has fewer side effects.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06700382

• Reducing chemotherapy for HER2 positive breast cancer patients

  This study is testing if using less chemotherapy can still be effective for patients with HER2 positive breast cancer while reducing side effects.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06700369

• Using teclistamab to treat systemic AL amyloidosis

  This study is testing if teclistamab can help people with systemic AL amyloidosis who haven't responded to other treatments by seeing if it can eliminate harmful plasma cells and improve their health.

  Recruiting at 2 sites Peking University People's Hospital · Beijing, Beijing Municipality and 1 other locations · NCT06699394

• Maintenance treatment for multiple myeloma after stem cell transplantation based on risk and MRD status

  This study is testing if different maintenance treatments after stem cell transplantation can help people with multiple myeloma feel better, depending on their risk level and if they still have cancer cells in their blood.

  Recruiting at 4 sites Peking University People's Hospital · Beijing, Beijing Municipality and 3 other locations · NCT06697483

• Choosing adjuvant therapy for HER2 positive early breast cancer after initial treatment

  This study is testing whether a combination of trastuzumab and pertuzumab works better than T-DM1 for people with HER2 positive breast cancer who still have cancer after their initial treatment.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06693037

• Using Neratinib for Early HER2 Positive Breast Cancer Treatment

  This study is testing if taking neratinib after standard treatments can help people with early HER2 positive breast cancer live longer without the disease coming back.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06693024

• Reducing chemotherapy for triple negative breast cancer with immunotherapy

  This study is testing whether giving less chemotherapy along with immunotherapy can help people with triple negative breast cancer respond better to treatment.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06692725

• Haploidentical stem cell transplantation for myelofibrosis

  This study is testing a new type of stem cell transplant for people with myelofibrosis to see if it can help those who don’t have a matched donor and improve their chances of recovery.

  Recruiting Peking University People's Hospital · Beijing · NCT06674382

• Using ICG imaging to improve surgery for giant cell tumors of bone

  This study is testing if a special imaging technique can help surgeons find and remove all parts of giant cell tumors in the bone to reduce the chances of them coming back after surgery.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06647901

• Predicting organ response in AL amyloidosis treatment

  This study is testing if measuring the quick response of certain proteins in the blood can help predict how well patients with AL amyloidosis will respond to treatment with daratumumab, bortezomib, and dexamethasone.

  Recruiting at 8 sites Peking University People's Hospital · Beijing, Beijing Municipality and 7 other locations · NCT06627309

• Evaluating CAR-T cell therapy with or without stem cell transplantation for relapsed B-cell leukemia

  This study tests if adding a stem cell transplant after CAR-T cell therapy can help young people with relapsed B-cell leukemia live longer and feel better.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06581081

• Evaluating stem cells in myelodysplastic syndromes using advanced flow cytometry

  This study is trying to see if certain stem cells can help predict how well patients with myelodysplastic syndromes will do after they receive a stem cell transplant.

  Recruiting at 4 sites Peking University People's Hospital · Beijing and 3 other locations · NCT06569095

• PD-1 inhibitor with progesterone to preserve fertility in early‑stage MMRd endometrial cancer

  This study tests whether giving a PD-1 inhibitor together with progesterone can help young patients with early, MMRd endometrial cancer preserve fertility.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06549855

• Modified second transplantation for patients with graft failure

  This study is testing a new approach to a second stem cell transplant for patients who didn't fully recover after their first transplant to see if it helps them get better, especially with their platelet counts.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06512545

• Second haploidentical stem cell transplantation for graft failure

  This study is testing if a second stem cell transplant from a partially matched donor can help patients with blood cancers who had problems with their first transplant.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06512519

• Examining how environmental factors affect gut bacteria in infants

  This study is looking at how different environmental factors affect the gut bacteria of newborns to better understand their development.

  Recruiting Peking University People's Hospital · Beijing · NCT06479928

• Fertility-sparing therapy for early-stage grade 2 endometrial cancer

  This trial tests whether using a progesterone-only therapy, alone or with combined treatment, can preserve fertility in women with stage IA, grade 2 endometrioid endometrial cancer.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06468215

• Detecting leukemia stem cells in blood and bone marrow to predict relapse in acute leukemia

  This study is testing if finding leukemia stem cells in the blood and bone marrow can help doctors predict relapses in children under 18 with acute leukemia.

  Recruiting at 2 sites Peking University People's Hospital · Beijing, Beijing Municipality and 1 other locations · NCT06452732

• Treatment for newly diagnosed monoclonal immunoglobulin deposition disease

  This study is testing a new combination treatment for people who have just been diagnosed with monoclonal immunoglobulin deposition disease to see if it helps improve their blood health.

  Recruiting at 3 sites Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality and 2 other locations · NCT06418477

• Third-generation TKI combined with azacitidine and a Bcl-2 inhibitor for CML in myeloid blast phase

  This study will test whether adding a third-generation TKI to azacitidine and a Bcl-2 inhibitor helps adults with Philadelphia chromosome–positive chronic myeloid leukemia in myeloid blast phase.

  Recruiting at 8 sites Peking University People's Hospital · Beijing, Beijing Municipality and 14 other locations · NCT06390306

• Treatment for systemic AL amyloidosis using bortezomib, pomalidomide, and dexamethasone

  This study is testing a new combination of medications to see if it can help people with systemic AL amyloidosis feel better and improve their blood health.

  Recruiting Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06342466

• Weekly irinotecan liposomes for Ewing Sarcoma

  This study tests if a new way of giving irinotecan, using liposomes, can help people with tough cases of Ewing Sarcoma feel better and improve their treatment results.

  Recruiting Phase 1 Peking University People's Hospital · Jina, Shandong and 2 other locations · NCT06340204

• Combining Narlumosbartmab with chemotherapy for bone tumors

  This study is testing whether adding a new drug called narlumosbartmab to standard chemotherapy can help people with certain types of bone tumors do better and have fewer problems after surgery.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06302465

• MRD response-adapted treatment for high-risk acute myeloid leukemia

  This study is testing a new way to treat high-risk acute myeloid leukemia by personalizing stem cell transplant plans based on how much leukemia is still detectable after initial treatment.

  Recruiting Peking University People's Hospital · Beijing · NCT06301425

• Monitoring residual disease in leukemia patients after stem cell transplantation

  This study is testing a new digital method to see if it can better track leftover leukemia cells in patients after they receive a stem cell transplant compared to older methods.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT06211166

• Using off-the-shelf CAR-NK cells to treat relapsed or refractory acute myeloid leukemia

  This study is testing a new treatment using specially modified immune cells to see if they can help people with relapsed or hard-to-treat acute myeloid leukemia feel better.

  Recruiting Early Phase 1 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06201247

• Optimizing first-line treatment for AL amyloidosis with specific genetic markers

  This study is testing a new treatment plan for people with AL amyloidosis who have a specific genetic marker to see if it helps them respond better and faster to their first-line therapy.

  Recruiting at 7 sites Peking University People's Hospital · Beijing, Beijing Municipality and 6 other locations · NCT06192979

• Weight management for overweight endometrial cancer patients undergoing fertility-sparing treatment

  This study tests if a weight management program can help overweight women with endometrial cancer who want to preserve their fertility feel better and improve their treatment results.

  Recruiting Peking University People's Hospital · Beijing, China · NCT06169449

• Using interferon-α to prevent relapse in myeloid malignancies after stem cell transplantation

  This study is testing if a treatment called interferon-α can help prevent relapse in patients with acute myeloid leukemia or myelodysplastic syndrome who have a specific gene mutation and are in remission after a stem cell transplant.

  Recruiting Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06130579

• Combining progesterone and statins for young women with early endometrial cancer and atypical hyperplasia

  This study is testing whether combining progesterone with statins can help young women with early endometrial cancer and atypical hyperplasia while preserving their ability to have children.

  Recruiting Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT06102863

• Fertility-sparing therapy for early-stage endometrial cancer

  This study is testing a new treatment approach for women with early-stage endometrial cancer to see if it can help them keep their ability to have children while also checking how well it works over time.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT05945407

• Mini-dose MTX combined with standard-dose steroids for treating acute GVHD

  This study is testing if a low dose of methotrexate combined with standard steroids can help people with acute graft-versus-host disease feel better compared to just using the standard steroids alone.

  Recruiting at 2 sites Phase 3 Peking University People's Hospital · Beijing, Beijing Municipality and 1 other locations · NCT05921305

• Evaluating Haplo-HSCT for Elderly Patients with Acute Leukemia or Myelodysplastic Syndrome

  This study is testing a gentler stem cell transplant method for older patients with acute leukemia or myelodysplastic syndromes who don't have a matched donor, to see if it helps them live longer and stay healthier after the procedure.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT05902416

• Evaluating autologous stem cell transplant for high-risk diffuse large B-cell lymphoma

  This study is testing if using a stem cell transplant after standard chemotherapy can help people with high-risk diffuse large B-cell lymphoma feel better and stay healthy longer.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT05831865

• Predicting progesterone sensitivity in early endometrial cancer patients

  This study is testing a new way to predict how well early endometrial cancer patients will respond to progesterone treatments using their own tumor cells.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT05647109

• Fluzoparib with Camrelizumab before surgery for BRCA-mutated, HER2-negative breast cancer

  This study tests whether the drug combo fluzoparib and camrelizumab can shrink BRCA-mutated, HER2-negative breast tumors before surgery in eligible patients.

  Recruiting Phase 2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT05576389

• Exploring the progression of angle-closure glaucoma over five years

  This study looks at how often people with early signs of angle-closure glaucoma develop more serious forms of the disease over five years to help find ways to prevent vision loss.

  Recruiting Peking University People's Hospital · Beijing, Beeijing · NCT05563623

• Predicting treatment outcomes and recurrence risk in high-risk GIST patients using liquid biopsy

  This study is trying to see if analyzing blood samples for tumor DNA can help doctors predict treatment success and the chance of cancer coming back in patients with high-risk gastrointestinal stromal tumors.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT05408897

• Understanding tumor evolution in early-stage non-small cell lung cancer

  This study is trying to understand how early-stage non-small cell lung cancer changes over time by looking at tumor samples and DNA to help improve treatment and monitoring for patients.

  Recruiting Peking University People's Hospital · Beijing · NCT05352035

• Guided chemotherapy for HER2-negative early breast cancer using drug screening

  This study is testing a new way to choose the best chemotherapy drugs for people with early HER2-negative breast cancer by using lab tests on their tumor cells before treatment starts.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing · NCT04836156

• Neoadjuvant therapy guided by drug screening for HER2 positive early breast cancer

  This study is testing if certain patients with early HER2-positive breast cancer can skip chemotherapy by using drug screening to find out which treatments work best for them.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT04750122

• Comparing two methods of radiotherapy and chemotherapy for stage III endometrial cancer

  This study is testing which treatment method—chemotherapy followed by radiotherapy or both together—works better for people with stage III endometrial cancer.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT04453904

Quick answers

How many clinical trials run by Peking University People's Hospital are recruiting right now?

126, as of November 12, 2026. 4 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 19, Phase 1/2: 9, Phase 1: 6, Early Phase 1: 5. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →